L. Jurga et al., AMELIORATION OF DOXORUBICIN CARDIOTOXICITY BY THE BISPIPERAZINEDIONE ICRF-187 IN WOMEN WITH ADVANCED BREAST-CANCER - A PRELIMINARY-REPORT, Neoplasma, 40(4), 1993, pp. 259-262
ICRF-187 seems to offer significant protection against cardiac toxicit
y caused by doxorubicin, without affecting the antitumor effect or the
incidence of noncardiac reactions.